{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T19:22:48Z","timestamp":1792264968242,"version":"4.4.0"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2021,4,26]],"date-time":"2021-04-26T00:00:00Z","timestamp":1619395200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,4,26]],"date-time":"2021-04-26T00:00:00Z","timestamp":1619395200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1007\/s12035-021-02397-8","type":"journal-article","created":{"date-parts":[[2021,4,26]],"date-time":"2021-04-26T22:03:49Z","timestamp":1619474629000},"page":"3992-4006","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Withaferin A Induces Heat Shock Response and Ameliorates Disease Progression in a Mouse Model of Huntington\u2019s Disease"],"prefix":"10.1007","volume":"58","author":[{"given":"Tripti","family":"Joshi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vipendra","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena V.","family":"Kaznacheyeva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6549-4211","authenticated-orcid":false,"given":"Nihar Ranjan","family":"Jana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,4,26]]},"reference":[{"issue":"3","key":"2397_CR1","doi-asserted-by":"publisher","first-page":"189","DOI":"10.2190\/HU6W-3K7Q-NAEL-XU6K","volume":"24","author":"MF Mendez","year":"1994","unstructured":"Mendez MF (1994) Huntington\u2019s disease: update and review of neuropsychiatric aspects. Int J Psychiatry Med 24(3):189\u2013208. https:\/\/doi.org\/10.2190\/HU6W-3K7Q-NAEL-XU6K","journal-title":"Int J Psychiatry Med"},{"key":"2397_CR2","doi-asserted-by":"publisher","first-page":"15005","DOI":"10.1038\/nrdp.2015.5","volume":"1","author":"GP Bates","year":"2015","unstructured":"Bates GP, Dorsey R, Gusella JF, Hayden MR, Kay C, Leavitt BR, Nance M, Ross CA et al (2015) Huntington disease Nat Rev Dis Primers 1:15005. https:\/\/doi.org\/10.1038\/nrdp.2015.5","journal-title":"Huntington disease Nat Rev Dis Primers"},{"issue":"6","key":"2397_CR3","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","volume":"72","author":"The Huntington\u2019s Disease Collaborative Research Group","year":"1993","unstructured":"The Huntington\u2019s Disease Collaborative Research Group (1993) A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington\u2019s disease chromosomes. Cell 72(6):971\u2013983. https:\/\/doi.org\/10.1016\/0092-8674(93)90585-E","journal-title":"Cell"},{"issue":"4","key":"2397_CR4","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1038\/ng0896-442","volume":"13","author":"YP Goldberg","year":"1996","unstructured":"Goldberg YP, Nicholson DW, Rasper DM, Kalchman MA, Koide HB, Graham RK, Bromm M, Kazemi-Esfarjani P et al (1996) Cleavage of huntingtin by apopain, a proapoptotic cysteine protease, is modulated by the polyglutamine tract. Nat Genet 13(4):442\u2013449. https:\/\/doi.org\/10.1038\/ng0896-442","journal-title":"Nat Genet"},{"issue":"5334","key":"2397_CR5","doi-asserted-by":"publisher","first-page":"1990","DOI":"10.1126\/science.277.5334.1990","volume":"277","author":"M DiFiglia","year":"1997","unstructured":"DiFiglia M, Sapp E, Chase KO, Davies SW, Bates GP, Vonsattel JP, Aronin N (1997) Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. Science 277(5334):1990\u20131993","journal-title":"Science"},{"key":"2397_CR6","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1146\/annurev.neuro.29.051605.113042","volume":"30","author":"HT Orr","year":"2007","unstructured":"Orr HT, Zoghbi HY (2007) Trinucleotide repeat disorders. Annu Rev Neurosci 30:575\u2013621. https:\/\/doi.org\/10.1146\/annurev.neuro.29.051605.113042","journal-title":"Annu Rev Neurosci"},{"issue":"10","key":"2397_CR7","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1038\/sj.embor.7400250","volume":"5","author":"C Landles","year":"2004","unstructured":"Landles C, Bates GP (2004) Huntingtin and the molecular pathogenesis of Huntington\u2019s disease. Fourth in molecular medicine review series. EMBO Rep 5(10):958\u2013963. https:\/\/doi.org\/10.1038\/sj.embor.7400250","journal-title":"EMBO Rep"},{"issue":"1","key":"2397_CR8","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1097\/00005072-199501000-00013","volume":"54","author":"JC Hedreen","year":"1995","unstructured":"Hedreen JC, Folstein SE (1995) Early loss of neostriatal striosome neurons in Huntington\u2019s disease. J Neuropathol Exp Neurol 54(1):105\u2013120","journal-title":"J Neuropathol Exp Neurol"},{"issue":"4688","key":"2397_CR9","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1126\/science.3155875","volume":"227","author":"GA Graveland","year":"1985","unstructured":"Graveland GA, Williams RS, DiFiglia M (1985) Evidence for degenerative and regenerative changes in neostriatal spiny neurons in Huntington\u2019s disease. Science 227(4688):770\u2013773","journal-title":"Science"},{"issue":"6","key":"2397_CR10","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1097\/00005072-198511000-00003","volume":"44","author":"JP Vonsattel","year":"1985","unstructured":"Vonsattel JP, Myers RH, Stevens TJ, Ferrante RJ, Bird ED, Richardson EP Jr (1985) Neuropathological classification of Huntington\u2019s disease. J Neuropathol Exp Neurol 44(6):559\u2013577","journal-title":"J Neuropathol Exp Neurol"},{"issue":"10","key":"2397_CR11","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1038\/nrg1691","volume":"6","author":"JR Gatchel","year":"2005","unstructured":"Gatchel JR, Zoghbi HY (2005) Diseases of unstable repeat expansion: mechanisms and common principles. Nat Rev Genet 6(10):743\u2013755. https:\/\/doi.org\/10.1038\/nrg1691","journal-title":"Nat Rev Genet"},{"issue":"7113","key":"2397_CR12","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1038\/nature05290","volume":"443","author":"PT Lansbury","year":"2006","unstructured":"Lansbury PT, Lashuel HA (2006) A century-old debate on protein aggregation and neurodegeneration enters the clinic. Nature 443(7113):774\u2013779. https:\/\/doi.org\/10.1038\/nature05290","journal-title":"Nature"},{"key":"2397_CR13","doi-asserted-by":"publisher","first-page":"218","DOI":"10.3389\/fncel.2014.00218","volume":"8","author":"J Margulis","year":"2014","unstructured":"Margulis J, Finkbeiner S (2014) Proteostasis in striatal cells and selective neurodegeneration in Huntington\u2019s disease. Front Cell Neurosci 8:218. https:\/\/doi.org\/10.3389\/fncel.2014.00218","journal-title":"Front Cell Neurosci"},{"issue":"20","key":"2397_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1017\/S1462399403006549","volume":"5","author":"DC Rubinsztein","year":"2003","unstructured":"Rubinsztein DC, Carmichael J (2003) Huntington\u2019s disease: molecular basis of neurodegeneration. Expert Rev Mol Med 5(20):1\u201321. https:\/\/doi.org\/10.1017\/S1462399403006549","journal-title":"Expert Rev Mol Med"},{"issue":"2","key":"2397_CR15","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/S0891-0618(03)00029-2","volume":"26","author":"NR Jana","year":"2003","unstructured":"Jana NR, Nukina N (2003) Recent advances in understanding the pathogenesis of polyglutamine diseases: involvement of molecular chaperones and ubiquitin-proteasome pathway. J Chem Neuroanat 26(2):95\u2013101","journal-title":"J Chem Neuroanat"},{"issue":"7731","key":"2397_CR16","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1038\/s41586-018-0678-x","volume":"563","author":"RS Samant","year":"2018","unstructured":"Samant RS, Livingston CM, Sontag EM, Frydman J (2018) Distinct proteostasis circuits cooperate in nuclear and cytoplasmic protein quality control. Nature 563(7731):407\u2013411. https:\/\/doi.org\/10.1038\/s41586-018-0678-x","journal-title":"Nature"},{"issue":"7154","key":"2397_CR17","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1038\/nature06022","volume":"448","author":"EJ Bennett","year":"2007","unstructured":"Bennett EJ, Shaler TA, Woodman B, Ryu KY, Zaitseva TS, Becker CH, Bates GP, Schulman H et al (2007) Global changes to the ubiquitin system in Huntington\u2019s disease. Nature 448(7154):704\u2013708","journal-title":"Nature"},{"issue":"6","key":"2397_CR18","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1083\/jcb.200709080","volume":"180","author":"J Wang","year":"2008","unstructured":"Wang J, Wang CE, Orr A, Tydlacka S, Li SH, Li XJ (2008) Impaired ubiquitin-proteasome system activity in the synapses of Huntington\u2019s disease mice. J Cell Biol 180(6):1177\u20131189","journal-title":"J Cell Biol"},{"issue":"10","key":"2397_CR19","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1093\/hmg\/10.10.1049","volume":"10","author":"NR Jana","year":"2001","unstructured":"Jana NR, Zemskov EA, Wang G, Nukina N (2001) Altered proteasomal function due to the expression of polyglutamine-expanded truncated N-terminal huntingtin induces apoptosis by caspase activation through mitochondrial cytochrome c release. Hum Mol Genet 10(10):1049\u20131059","journal-title":"Hum Mol Genet"},{"issue":"7","key":"2397_CR20","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1016\/j.drudis.2014.02.014","volume":"19","author":"CJ Cortes","year":"2014","unstructured":"Cortes CJ, La Spada AR (2014) The many faces of autophagy dysfunction in Huntington\u2019s disease: from mechanism to therapy. Drug Discov Today 19(7):963\u2013971","journal-title":"Drug Discov Today"},{"issue":"1","key":"2397_CR21","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1038\/cdd.2008.110","volume":"16","author":"S Sarkar","year":"2009","unstructured":"Sarkar S, Ravikumar B, Floto RA, Rubinsztein DC (2009) Rapamycin and mTOR-independent autophagy inducers ameliorate toxicity of polyglutamine-expanded huntingtin and related proteinopathies. Cell Death Differ 16(1):46\u201356","journal-title":"Cell Death Differ"},{"issue":"7113","key":"2397_CR22","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1038\/nature05291","volume":"443","author":"DC Rubinsztein","year":"2006","unstructured":"Rubinsztein DC (2006) The roles of intracellular protein-degradation pathways in neurodegeneration. Nature 443(7113):780\u2013786","journal-title":"Nature"},{"key":"2397_CR23","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.freeradbiomed.2019.11.021","volume":"146","author":"BR Pinho","year":"2020","unstructured":"Pinho BR, Duarte AI, Canas PM, Moreira PI, Murphy MP, Oliveira JMA (2020) The interplay between redox signalling and proteostasis in neurodegeneration: in vivo effects of a mitochondria-targeted antioxidant in Huntington\u2019s disease mice. Free Radic Biol Med 146:372\u2013382. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2019.11.021","journal-title":"Free Radic Biol Med"},{"issue":"6","key":"2397_CR24","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1038\/ng1362","volume":"36","author":"B Ravikumar","year":"2004","unstructured":"Ravikumar B, Vacher C, Berger Z, Davies JE, Luo S, Oroz LG, Scaravilli F, Easton DF et al (2004) Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease. Nat Genet 36(6):585\u2013595. https:\/\/doi.org\/10.1038\/ng1362","journal-title":"Nat Genet"},{"issue":"1","key":"2397_CR25","doi-asserted-by":"publisher","first-page":"2886","DOI":"10.1038\/s41467-018-05320-3","volume":"9","author":"S Koyuncu","year":"2018","unstructured":"Koyuncu S, Saez I, Lee HJ, Gutierrez-Garcia R, Pokrzywa W, Fatima A, Hoppe T, Vilchez D (2018) The ubiquitin ligase UBR5 suppresses proteostasis collapse in pluripotent stem cells from Huntington\u2019s disease patients. Nat Commun 9(1):2886. https:\/\/doi.org\/10.1038\/s41467-018-05320-3","journal-title":"Nat Commun"},{"key":"2397_CR26","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.arr.2018.11.006","volume":"49","author":"TR Soares","year":"2019","unstructured":"Soares TR, Reis SD, Pinho BR, Duchen MR, Oliveira JMA (2019) Targeting the proteostasis network in Huntington\u2019s disease. Ageing Res Rev 49:92\u2013103. https:\/\/doi.org\/10.1016\/j.arr.2018.11.006","journal-title":"Ageing Res Rev"},{"issue":"10","key":"2397_CR27","doi-asserted-by":"publisher","first-page":"2737","DOI":"10.1093\/hmg\/ddt667","volume":"23","author":"M Maheshwari","year":"2014","unstructured":"Maheshwari M, Bhutani S, Das A, Mukherjee R, Sharma A, Kino Y, Nukina N, Jana NR (2014) Dexamethasone induces heat shock response and slows down disease progression in mouse and fly models of Huntington\u2019s disease. Hum Mol Genet 23(10):2737\u20132751","journal-title":"Hum Mol Genet"},{"issue":"12","key":"2397_CR28","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1038\/nrd3453","volume":"10","author":"DW Neef","year":"2011","unstructured":"Neef DW, Jaeger AM, Thiele DJ (2011) Heat shock transcription factor 1 as a therapeutic target in neurodegenerative diseases. Nat Rev Drug Discov 10(12):930\u2013944","journal-title":"Nat Rev Drug Discov"},{"issue":"8","key":"2397_CR29","doi-asserted-by":"publisher","first-page":"6337","DOI":"10.1007\/s12035-017-0853-3","volume":"55","author":"BK Singh","year":"2018","unstructured":"Singh BK, Vatsa N, Nelson VK, Kumar V, Kumar SS, Mandal SC, Pal M, Jana NR (2018) Azadiradione restores protein quality control and ameliorates the disease pathogenesis in a mouse model of Huntington\u2019s disease. Mol Neurobiol 55(8):6337\u20136346. https:\/\/doi.org\/10.1007\/s12035-017-0853-3","journal-title":"Mol Neurobiol"},{"key":"2397_CR30","doi-asserted-by":"publisher","first-page":"14405","DOI":"10.1038\/ncomms14405","volume":"8","author":"R Gomez-Pastor","year":"2017","unstructured":"Gomez-Pastor R, Burchfiel ET, Neef DW, Jaeger AM, Cabiscol E, McKinstry SU, Doss A, Aballay A et al (2017) Abnormal degradation of the neuronal stress-protective transcription factor HSF1 in Huntington\u2019s disease. Nat Commun 8:14405","journal-title":"Nat Commun"},{"issue":"5","key":"2397_CR31","doi-asserted-by":"publisher","first-page":"e37929","DOI":"10.1371\/journal.pone.0037929","volume":"7","author":"SM Chafekar","year":"2012","unstructured":"Chafekar SM, Duennwald ML (2012) Impaired heat shock response in cells expressing full-length polyglutamine-expanded huntingtin. PLoS ONE 7(5):e37929. https:\/\/doi.org\/10.1371\/journal.pone.0037929","journal-title":"PLoS ONE"},{"issue":"41","key":"2397_CR32","doi-asserted-by":"publisher","first-page":"34908","DOI":"10.1074\/jbc.M506288200","volume":"280","author":"M Fujimoto","year":"2005","unstructured":"Fujimoto M, Takaki E, Hayashi T, Kitaura Y, Tanaka Y, Inouye S, Nakai A (2005) Active HSF1 significantly suppresses polyglutamine aggregate formation in cellular and mouse models. J Biol Chem 280(41):34908\u201334916","journal-title":"J Biol Chem"},{"issue":"12","key":"2397_CR33","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1093\/hmg\/10.12.1307","volume":"10","author":"A Sittler","year":"2001","unstructured":"Sittler A, Lurz R, Lueder G, Priller J, Lehrach H, Hayer-Hartl MK, Hartl FU, Wanker EE (2001) Geldanamycin activates a heat shock response and inhibits huntingtin aggregation in a cell culture model of Huntington\u2019s disease. Hum Mol Genet 10(12):1307\u20131315","journal-title":"Hum Mol Genet"},{"issue":"8","key":"2397_CR34","doi-asserted-by":"publisher","first-page":"3306","DOI":"10.1172\/JCI57413","volume":"121","author":"J Labbadia","year":"2011","unstructured":"Labbadia J, Cunliffe H, Weiss A, Katsyuba E, Sathasivam K, Seredenina T, Woodman B, Moussaoui S et al (2011) Altered chromatin architecture underlies progressive impairment of the heat shock response in mouse models of Huntington disease. J Clin Invest 121(8):3306\u20133319","journal-title":"J Clin Invest"},{"issue":"53","key":"2397_CR35","doi-asserted-by":"publisher","first-page":"56053","DOI":"10.1074\/jbc.M409267200","volume":"279","author":"SD Westerheide","year":"2004","unstructured":"Westerheide SD, Bosman JD, Mbadugha BN, Kawahara TL, Matsumoto G, Kim S, Gu W, Devlin JP et al (2004) Celastrols as inducers of the heat shock response and cytoprotection. J Biol Chem 279(53):56053\u201356060","journal-title":"J Biol Chem"},{"issue":"4","key":"2397_CR36","first-page":"334","volume":"5","author":"LC Mishra","year":"2000","unstructured":"Mishra LC, Singh BB, Dagenais S (2000) Scientific basis for the therapeutic use of Withania somnifera (ashwagandha): a review. Altern Med Rev 5(4):334\u2013346","journal-title":"Altern Med Rev"},{"issue":"6","key":"2397_CR37","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1248\/bpb.b14-00022","volume":"37","author":"T Kuboyama","year":"2014","unstructured":"Kuboyama T, Tohda C, Komatsu K (2014) Effects of Ashwagandha (roots of Withania somnifera) on neurodegenerative diseases. Biol Pharm Bull 37(6):892\u2013897. https:\/\/doi.org\/10.1248\/bpb.b14-00022","journal-title":"Biol Pharm Bull"},{"issue":"12","key":"2397_CR38","doi-asserted-by":"publisher","first-page":"2429","DOI":"10.1084\/jem.20111313","volume":"208","author":"V Swarup","year":"2011","unstructured":"Swarup V, Phaneuf D, Dupre N, Petri S, Strong M, Kriz J, Julien JP (2011) Deregulation of TDP-43 in amyotrophic lateral sclerosis triggers nuclear factor kappaB-mediated pathogenic pathways. J Exp Med 208(12):2429\u20132447. https:\/\/doi.org\/10.1084\/jem.20111313","journal-title":"J Exp Med"},{"issue":"1","key":"2397_CR39","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/s13311-014-0311-0","volume":"12","author":"P Patel","year":"2015","unstructured":"Patel P, Julien JP, Kriz J (2015) Early-stage treatment with Withaferin A reduces levels of misfolded superoxide dismutase 1 and extends lifespan in a mouse model of amyotrophic lateral sclerosis. Neurotherapeutics 12(1):217\u2013233. https:\/\/doi.org\/10.1007\/s13311-014-0311-0","journal-title":"Neurotherapeutics"},{"key":"2397_CR40","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.expneurol.2018.08.008","volume":"309","author":"K Dutta","year":"2018","unstructured":"Dutta K, Patel P, Julien JP (2018) Protective effects of Withania somnifera extract in SOD1(G93A) mouse model of amyotrophic lateral sclerosis. Exp Neurol 309:193\u2013204. https:\/\/doi.org\/10.1016\/j.expneurol.2018.08.008","journal-title":"Exp Neurol"},{"issue":"2","key":"2397_CR41","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1007\/s13311-016-0499-2","volume":"14","author":"K Dutta","year":"2017","unstructured":"Dutta K, Patel P, Rahimian R, Phaneuf D, Julien JP (2017) Withania somnifera reverses transactive response DNA binding protein 43 proteinopathy in a mouse model of amyotrophic lateral sclerosis\/frontotemporal lobar degeneration. Neurotherapeutics 14(2):447\u2013462. https:\/\/doi.org\/10.1007\/s13311-016-0499-2","journal-title":"Neurotherapeutics"},{"issue":"9","key":"2397_CR42","doi-asserted-by":"publisher","first-page":"3510","DOI":"10.1073\/pnas.1112209109","volume":"109","author":"N Sehgal","year":"2012","unstructured":"Sehgal N, Gupta A, Valli RK, Joshi SD, Mills JT, Hamel E, Khanna P, Jain SC, Thakur SS, Ravindranath V (2012) Withania somnifera reverses Alzheimer\u2019s disease pathology by enhancing low-density lipoprotein receptor-related protein in liver. Proc Natl Acad Sci U S A 109(9):3510\u20133515. https:\/\/doi.org\/10.1073\/pnas.1112209109","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"2397_CR43","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1021\/cb200353m","volume":"7","author":"S Santagata","year":"2012","unstructured":"Santagata S, Xu YM, Wijeratne EM, Kontnik R, Rooney C, Perley CC, Kwon H, Clardy J, Kesari S, Whitesell L, Lindquist S, Gunatilaka AA (2012) Using the heat-shock response to discover anticancer compounds that target protein homeostasis. ACS Chem Biol 7(2):340\u2013349. https:\/\/doi.org\/10.1021\/cb200353m","journal-title":"ACS Chem Biol"},{"issue":"11","key":"2397_CR44","doi-asserted-by":"publisher","first-page":"e50547","DOI":"10.1371\/journal.pone.0050547","volume":"7","author":"S Khan","year":"2012","unstructured":"Khan S, Rammeloo AW, Heikkila JJ (2012) Withaferin A induces proteasome inhibition, endoplasmic reticulum stress, the heat shock response and acquisition of thermotolerance. PLoS ONE 7(11):e50547. https:\/\/doi.org\/10.1371\/journal.pone.0050547","journal-title":"PLoS ONE"},{"issue":"23","key":"2397_CR45","doi-asserted-by":"publisher","first-page":"6235","DOI":"10.1093\/hmg\/ddu343","volume":"23","author":"M Maheshwari","year":"2014","unstructured":"Maheshwari M, Shekhar S, Singh BK, Jamal I, Vatsa N, Kumar V, Sharma A, Jana NR (2014) Deficiency of Ube3a in Huntington\u2019s disease mice brain increases aggregate load and accelerates disease pathology. Hum Mol Genet 23(23):6235\u20136245","journal-title":"Hum Mol Genet"},{"issue":"2","key":"2397_CR46","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1002\/ana.24406","volume":"78","author":"J Drouin-Ouellet","year":"2015","unstructured":"Drouin-Ouellet J, Sawiak SJ, Cisbani G, Lagace M, Kuan WL, Saint-Pierre M, Dury RJ, Alata W, St-Amour I, Mason SL, Calon F, Lacroix S, Gowland PA, Francis ST, Barker RA, Cicchetti F (2015) Cerebrovascular and blood-brain barrier impairments in Huntington\u2019s disease: potential implications for its pathophysiology. Ann Neurol 78(2):160\u2013177. https:\/\/doi.org\/10.1002\/ana.24406","journal-title":"Ann Neurol"},{"issue":"1","key":"2397_CR47","doi-asserted-by":"publisher","first-page":"7202","DOI":"10.1038\/s41598-019-43627-3","volume":"9","author":"J Pido-Lopez","year":"2019","unstructured":"Pido-Lopez J, Tanudjojo B, Farag S, Bondulich MK, Andre R, Tabrizi SJ, Bates GP (2019) Inhibition of tumour necrosis factor alpha in the R6\/2 mouse model of Huntington\u2019s disease by etanercept treatment. Sci Rep 9(1):7202. https:\/\/doi.org\/10.1038\/s41598-019-43627-3","journal-title":"Sci Rep"},{"issue":"21","key":"2397_CR48","doi-asserted-by":"publisher","first-page":"4307","DOI":"10.1038\/sj.emboj.7600426","volume":"23","author":"CI Holmberg","year":"2004","unstructured":"Holmberg CI, Staniszewski KE, Mensah KN, Matouschek A, Morimoto RI (2004) Inefficient degradation of truncated polyglutamine proteins by the proteasome. EMBO J 23(21):4307\u20134318. https:\/\/doi.org\/10.1038\/sj.emboj.7600426","journal-title":"EMBO J"},{"issue":"13","key":"2397_CR49","doi-asserted-by":"publisher","first-page":"2009","DOI":"10.1093\/hmg\/9.13.2009","volume":"9","author":"NR Jana","year":"2000","unstructured":"Jana NR, Tanaka M, Wang G, Nukina N (2000) Polyglutamine length-dependent interaction of Hsp40 and Hsp70 family chaperones with truncated N-terminal huntingtin: their role in suppression of aggregation and cellular toxicity. Hum Mol Genet 9(13):2009\u20132018. https:\/\/doi.org\/10.1093\/hmg\/9.13.2009","journal-title":"Hum Mol Genet"},{"issue":"13","key":"2397_CR50","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1093\/hmg\/ddh144","volume":"13","author":"DG Hay","year":"2004","unstructured":"Hay DG, Sathasivam K, Tobaben S, Stahl B, Marber M, Mestril R, Mahal A, Smith DL, Woodman B, Bates GP (2004) Progressive decrease in chaperone protein levels in a mouse model of Huntington\u2019s disease and induction of stress proteins as a therapeutic approach. Hum Mol Genet 13(13):1389\u20131405. https:\/\/doi.org\/10.1093\/hmg\/ddh144","journal-title":"Hum Mol Genet"},{"issue":"1","key":"2397_CR51","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1038\/nm.2558","volume":"18","author":"M Jiang","year":"2011","unstructured":"Jiang M, Wang J, Fu J, Du L, Jeong H, West T, Xiang L, Peng Q, Hou Z, Cai H, Seredenina T, Arbez N, Zhu S, Sommers K, Qian J, Zhang J, Mori S, Yang XW, Tamashiro KL, Aja S, Moran TH, Luthi-Carter R, Martin B, Maudsley S, Mattson MP, Cichewicz RH, Ross CA, Holtzman DM, Krainc D, Duan W (2011) Neuroprotective role of Sirt1 in mammalian models of Huntington\u2019s disease through activation of multiple Sirt1 targets. Nat Med 18(1):153\u2013158. https:\/\/doi.org\/10.1038\/nm.2558","journal-title":"Nat Med"},{"key":"2397_CR52","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.mcn.2017.12.009","volume":"88","author":"RH Reynolds","year":"2018","unstructured":"Reynolds RH, Petersen MH, Willert CW, Heinrich M, Nymann N, Dall M, Treebak JT, Bjorkqvist M, Silahtaroglu A, Hasholt L, Norremolle A (2018) Perturbations in the p53\/miR-34a\/SIRT1 pathway in the R6\/2 Huntington\u2019s disease model. Mol Cell Neurosci 88:118\u2013129. https:\/\/doi.org\/10.1016\/j.mcn.2017.12.009","journal-title":"Mol Cell Neurosci"},{"issue":"38","key":"2397_CR53","doi-asserted-by":"publisher","first-page":"26188","DOI":"10.1074\/jbc.M710521200","volume":"283","author":"N Fujikake","year":"2008","unstructured":"Fujikake N, Nagai Y, Popiel HA, Okamoto Y, Yamaguchi M, Toda T (2008) Heat shock transcription factor 1-activating compounds suppress polyglutamine-induced neurodegeneration through induction of multiple molecular chaperones. J Biol Chem 283(38):26188\u201326197","journal-title":"J Biol Chem"},{"issue":"35","key":"2397_CR54","doi-asserted-by":"publisher","first-page":"17383","DOI":"10.1073\/pnas.1900055116","volume":"116","author":"L Matai","year":"2019","unstructured":"Matai L, Sarkar GC, Chamoli M, Malik Y, Kumar SS, Rautela U, Jana NR, Chakraborty K, Mukhopadhyay A (2019) Dietary restriction improves proteostasis and increases life span through endoplasmic reticulum hormesis. Proc Natl Acad Sci U S A 116(35):17383\u201317392. https:\/\/doi.org\/10.1073\/pnas.1900055116","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2397_CR55","doi-asserted-by":"publisher","first-page":"112769","DOI":"10.1016\/j.jep.2020.112769","volume":"256","author":"NJ Dar","year":"2020","unstructured":"Dar NJ, Ahmad Muzamil (2020) Neurodegenerative diseases and Withaniasomnifera (L.): an update. J Ethnopharmacol 256:112769. https:\/\/doi.org\/10.1016\/j.jep.2020.112769","journal-title":"J Ethnopharmacol"},{"key":"2397_CR56","doi-asserted-by":"publisher","DOI":"10.1007\/s13311-020-00952-0","author":"S Kumar","year":"2020","unstructured":"Kumar S, Phaneuf D, Julien JP (2020) Withaferin-A treatment alleviates TAR DNA-binding protein-43 pathology and improves cognitive function in a mouse model of FTLD. Neurotherapeutics. https:\/\/doi.org\/10.1007\/s13311-020-00952-0","journal-title":"Neurotherapeutics"},{"issue":"4","key":"2397_CR57","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/j.bcp.2014.08.004","volume":"91","author":"K Heyninck","year":"2014","unstructured":"Heyninck K, Lahtela-Kakkonen M, Van der Veken P, Haegeman G, Vanden Berghe W (2014) Withaferin A inhibits NF-kappaB activation by targeting cysteine 179 in IKKbeta. Biochem Pharmacol 91(4):501\u2013509. https:\/\/doi.org\/10.1016\/j.bcp.2014.08.004","journal-title":"Biochem Pharmacol"},{"key":"2397_CR58","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/978-3-319-41334-1_14","volume":"928","author":"PT White","year":"2016","unstructured":"White PT, Subramanian C, Motiwala HF, Cohen MS (2016) Natural withanolides in the treatment of chronic diseases. Adv Exp Med Biol 928:329\u2013373. https:\/\/doi.org\/10.1007\/978-3-319-41334-1_14","journal-title":"Adv Exp Med Biol"},{"issue":"8","key":"2397_CR59","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1084\/jem.20080178","volume":"205","author":"M Bjorkqvist","year":"2008","unstructured":"Bjorkqvist M, Wild EJ, Thiele J, Silvestroni A, Andre R, Lahiri N, Raibon E, Lee RV, Benn CL, Soulet D, Magnusson A, Woodman B, Landles C, Pouladi MA, Hayden MR, Khalili-Shirazi A, Lowdell MW, Brundin P, Bates GP, Leavitt BR, Moller T, Tabrizi SJ (2008) A novel pathogenic pathway of immune activation detectable before clinical onset in Huntington\u2019s disease. J Exp Med 205(8):1869\u20131877. https:\/\/doi.org\/10.1084\/jem.20080178","journal-title":"J Exp Med"},{"issue":"Pt 3","key":"2397_CR60","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1093\/brain\/awt355","volume":"137","author":"U Trager","year":"2014","unstructured":"Trager U, Andre R, Lahiri N, Magnusson-Lind A, Weiss A, Grueninger S, McKinnon C, Sirinathsinghji E, Kahlon S, Pfister EL, Moser R, Hummerich H, Antoniou M, Bates GP, Luthi-Carter R, Lowdell MW, Bjorkqvist M, Ostroff GR, Aronin N, Tabrizi SJ (2014) HTT-lowering reverses Huntington\u2019s disease immune dysfunction caused by NFkappaB pathway dysregulation. Brain 137(Pt 3):819\u2013833. https:\/\/doi.org\/10.1093\/brain\/awt355","journal-title":"Brain"},{"key":"2397_CR61","doi-asserted-by":"publisher","first-page":"577380","DOI":"10.1016\/j.jneuroim.2020.577380","volume":"348","author":"PAC Valadao","year":"2020","unstructured":"Valadao PAC, Santos KBS, Ferreira EVTH, Macedo ECT, Teixeira AL, Guatimosim C, de Miranda AS (2020) Inflammation in Huntington\u2019s disease: a few new twists on an old tale. J Neuroimmunol 348:577380. https:\/\/doi.org\/10.1016\/j.jneuroim.2020.577380","journal-title":"J Neuroimmunol"},{"issue":"37","key":"2397_CR62","doi-asserted-by":"publisher","first-page":"7999","DOI":"10.1523\/JNEUROSCI.2675-04.2004","volume":"24","author":"A Khoshnan","year":"2004","unstructured":"Khoshnan A, Ko J, Watkin EE, Paige LA, Reinhart PH, Patterson PH (2004) Activation of the IkappaB kinase complex and nuclear factor-kappaB contributes to mutant huntingtin neurotoxicity. J Neurosci 24(37):7999\u20138008. https:\/\/doi.org\/10.1523\/JNEUROSCI.2675-04.2004","journal-title":"J Neurosci"},{"issue":"7","key":"2397_CR63","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1083\/jcb.200909067","volume":"187","author":"LM Thompson","year":"2009","unstructured":"Thompson LM, Aiken CT, Kaltenbach LS, Agrawal N, Illes K, Khoshnan A, Martinez-Vincente M, Arrasate M, O\u2019Rourke JG, Khashwji H, Lukacsovich T, Zhu YZ, Lau AL, Massey A, Hayden MR, Zeitlin SO, Finkbeiner S, Green KN, LaFerla FM, Bates G, Huang L, Patterson PH, Lo DC, Cuervo AM, Marsh JL, Steffan JS (2009) IKK phosphorylates Huntingtin and targets it for degradation by the proteasome and lysosome. J Cell Biol 187(7):1083\u20131099. https:\/\/doi.org\/10.1083\/jcb.200909067","journal-title":"J Cell Biol"},{"issue":"9","key":"2397_CR64","doi-asserted-by":"publisher","first-page":"1826","DOI":"10.1093\/hmg\/ddt036","volume":"22","author":"HY Hsiao","year":"2013","unstructured":"Hsiao HY, Chen YC, Chen HM, Tu PH, Chern Y (2013) A critical role of astrocyte-mediated nuclear factor-kappaB-dependent inflammation in Huntington\u2019s disease. Hum Mol Genet 22(9):1826\u20131842. https:\/\/doi.org\/10.1093\/hmg\/ddt036","journal-title":"Hum Mol Genet"},{"key":"2397_CR65","doi-asserted-by":"publisher","first-page":"625231","DOI":"10.3389\/fcell.2021.625231","volume":"9","author":"VA Vigont","year":"2021","unstructured":"Vigont VA, Grekhnev DA, Lebedeva OS, Gusev KO, Volovikov EA, Skopin AY, Bogomazova AN, Shuvalova LD, Zubkova OA, Khomyakova EA, Glushankova LN, Klyushnikov SA, Illarioshkin SN, Lagarkova MA, Kaznacheyeva EV (2021) STIM2 mediates excessive store-operated calcium entry in patient-specific iPSC-derived neurons modeling a juvenile form of Huntington\u2019s disease. Front Cell DevBiol 9:625231. https:\/\/doi.org\/10.3389\/fcell.2021.625231","journal-title":"Front Cell DevBiol"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-021-02397-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-021-02397-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-021-02397-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,15]],"date-time":"2021-07-15T03:48:20Z","timestamp":1626320900000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-021-02397-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,26]]},"references-count":65,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["2397"],"URL":"https:\/\/doi.org\/10.1007\/s12035-021-02397-8","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,26]]},"assertion":[{"value":"20 February 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 April 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}